IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes.
Saved in:
| Title: | IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes. |
|---|---|
| Authors: | Lay AC; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Hale LJ; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Stowell-Connolly H; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Pope RJP; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Nair V; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA., Ju W; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA., Marquez E; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Rollason R; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Hurcombe JA; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Hayes B; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Roberts T; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Gillam L; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Allington J; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Nelson RG; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA., Kretzler M; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA., Holly JMP; IGFs and Metabolic Endocrinology Group, Bristol Medical School, University of Bristol, Bristol, UK., Perks CM; IGFs and Metabolic Endocrinology Group, Bristol Medical School, University of Bristol, Bristol, UK., McArdle CA; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Welsh GI; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK., Coward RJM; Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK. Richard.Coward@bristol.ac.uk. |
| Source: | Diabetologia [Diabetologia] 2021 Jul; Vol. 64 (7), pp. 1690-1702. Date of Electronic Publication: 2021 Mar 24. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
